Telix Pharmaceuticals Lim... (TLX)
NASDAQ: TLX
· Real-Time Price · USD
10.23
-0.05 (-0.49%)
At close: Oct 06, 2025, 11:18 AM
Telix Pharmaceuticals Cash Flow Statement
Financials in AUD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Net Income | -15.16M | n/a | 31.21M | 5.21M | -47.51M | -104.08M | -118.89M | -80.51M | -59.1M |
Depreciation & Amortization | 12.57M | n/a | 5.63M | 6.92M | 5.94M | 5.4M | 5.37M | 5.44M | 5.36M |
Stock-Based Compensation | 17.6M | n/a | 7.47M | 8.79M | 7.16M | 8.11M | 1.5M | 1.32M | 2.88M |
Other Working Capital | -64.27M | -64.27M | -20.52M | -20.52M | -3.69M | -3.69M | 2.6M | 2.6M | -193K |
Other Non-Cash Items | 80.18M | 103.2M | 16.04M | 25.6M | 62.96M | 45.51M | 33.35M | 26.63M | 56.25M |
Deferred Income Tax | n/a | n/a | 42.78M | 42.78M | 16.89M | 16.89M | 5.52M | 5.52M | -5.46M |
Change in Working Capital | -64.27M | -64.27M | -57.53M | -57.53M | -28.64M | -28.64M | -7.42M | -7.42M | -612K |
Operating Cash Flow | 30.92M | 38.93M | 45.6M | 23.88M | 9.51M | -63.97M | -90.9M | -59.33M | -8.22M |
Capital Expenditures | -30.47M | -34.03M | -21.48M | -10.79M | -7.67M | -13.86M | -10.2M | -1.34M | -454K |
Cash Acquisitions | -360.47M | -34.69M | -23.31M | n/a | -850K | -973K | n/a | n/a | -322K |
Purchase of Investments | -51.99M | -51.99M | -13.15M | -13.15M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -59.41M | -33.95M | -10.28M | -1.54M | -25K | -2.16M | -3.08M | -1.39M | -449K |
Investing Cash Flow | -482.63M | -134.95M | -68.23M | -25.49M | -8.55M | -17M | -13.28M | -2.73M | -1.23M |
Debt Repayment | 647.34M | 654.31M | 2.14M | 639.28K | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -17.47M | -16.39M | 6.59M | 9.18M | 8.49M | 174.96M | 173.68M | 2.85M | 33.97M |
Financial Cash Flow | 630.86M | 638.92M | 9.1M | 10.19M | 8.49M | 174.96M | 173.68M | 2.85M | 33.97M |
Net Cash Flow | 906.26M | 587.64M | -12.36M | 6.91M | 9.12M | 94.29M | 72.99M | -55.91M | 25.24M |
Free Cash Flow | 5.92M | 9M | 22.75M | 13.09M | 1.83M | -77.83M | -101.1M | -60.67M | -8.67M |